Mode
Text Size
Log in / Sign up

Prediabetes Associated With Higher Incidence of Frailty and Functional Deficits in Adults Aged 50 Years or Older

Prediabetes Associated With Higher Incidence of Frailty and Functional Deficits in Adults Aged 50 Ye…
Photo by Mykenzie Johnson / Unsplash
Key Takeaway
Consider prediabetes a marker of metabolic vulnerability linked to biological aging and functional decline in older adults.

This pooled analysis utilized data from five nationally representative longitudinal aging cohorts including MHAS, HRS, CHARLS, ELSA, and CRELES involving 18,571 participants aged 50 years or older. Time-varying analyses included 7,840 participants. The study followed individuals for a median 13.6 years to assess glycemic transitions and functional capacity.

Baseline prediabetes was associated with increased progression of functional deficits and frailty compared with normoglycemia. Diabetes showed the strongest effects across all outcomes, while prediabetes showed a smaller increase with attenuation over time. Regression to normoglycemia occurred in 20.8% of individuals with baseline prediabetes. Progression to diabetes occurred in 24.3% of individuals with baseline prediabetes. Higher incidence rate ratios were estimated by mixed-effects Poisson models and generalized estimating equations.

Regression to normoglycemia was associated with increased incidence of ADL and frailty deficits. Progression to diabetes was associated with lower risk of incident ADL and Fried frailty deficits compared to stable prediabetes. Time-dependent changes in incidence rates were not significant for ADL, IADL, and multimorbidity deficits. Adverse events were not reported. Causality was not explicitly claimed. Prediabetes reflects metabolic vulnerability linked to biological aging rather than solely a precursor to diabetes. Outcomes included the FRAIL scale and deficit-accumulation Frailty Index. The analysis was supported by Instituto Nacional de Geriatria in Mexico.

Study Details

Study typeCohort
Sample sizen = 7,840
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Background: Prediabetes is highly prevalent in older adults and is characterized by heterogeneous clinical trajectories, including regression to normoglycemia and progression to diabetes. While prediabetes has been associated with impaired physical function and frailty, the longitudinal impact of both a single diagnosis and dynamic glycemic transitions on functional outcomes remains unclear. We aimed to evaluate associations between baseline prediabetes and glycemic transitions over time with trajectories of functional capacity and frailty in older adults. Methods: We conducted a pooled analysis of harmonized data from five nationally representative longitudinal aging cohorts (MHAS, HRS, CHARLS, ELSA, CRELES) within the Gateway to Global Aging Data, including adults aged [≥]50 years with [≥]1 HbA1c measurements. Prediabetes was defined per ADA criteria (HbA1c 5.7-6.4%). Functional outcomes included activities of daily living (ADL), instrumental ADL (IADL), and frailty assessed using Fried phenotype, FRAIL scale, and a deficit-accumulation Frailty Index (FI). Mixed-effects Poisson models estimated incidence rate ratios (IRRs) for baseline prediabetes, while generalized estimating equations assessed time-varying glycemic status and transition trajectories. Models were adjusted for age, sex, cohort, and time-varying covariates, with sensitivity analyses including BMI, smoking, and alcohol intake. Findings: Among 18,571 participants (median follow-up 13.6 years), baseline prediabetes was associated with increased progression of functional deficits and frailty compared with normoglycemia, including higher FI values and accelerated FI progression. Prediabetes was associated with higher incidence of ADL, IADL, and multimorbidity deficits from early follow-up, although time-dependent changes in incidence rates were not significant. In time-varying analyses (n=7,840), both prediabetes and diabetes were associated with higher incidence of functional deficits compared with normoglycemia, with diabetes showing the strongest effects across all outcomes. Diabetes was associated with greater FI burden and accelerated progression, whereas prediabetes showed a smaller increase, with attenuation over time. Among individuals with baseline prediabetes, regression to normoglycemia occurred in 20.8% and was associated with increased incidence of ADL and frailty deficits. In contrast, progression to diabetes occurred in 24.3%, and was associated with lower risk of incident ADL and Fried frailty deficits compared to stable prediabetes. Interpretation: Prediabetes is associated with increased risk of functional decline, frailty, and deficit accumulation in older adults, independent of progression to diabetes. Regression to normoglycemia was associated with higher risk of functional deterioration. These findings suggest that prediabetes reflects a state of metabolic vulnerability linked to biological aging rather than solely a precursor to diabetes and highlights a need to reframe its clinical significance in older populations. Funding: This research was supported by Instituto Nacional de Geriatria in Mexico. Keywords: Prediabetes; Glycemic transitions; Frailty; Functional decline; Aging; Multimorbidity
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.